Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of eculizumab for Guillain-Barré syndrome has completed, and full results were posted on 2024-02-09. T…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Guillain-barré Syndrome

Drugs mentioned

• SOLIRIS (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Guillain-Barre Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2024-02-09